FortePhest

Herbicides for Crop Protection

Agriculture & Food Technologies
Private

Company Overview

Snapshot

Founded in August 2017 by Alex Kozak, Israel Shapiro, and Mark Safro, FortePhest operates with 1–10 employees. The company has raised $1.4M across two funding rounds from three investors. In February 2022, FortePhest secured funding from BASF Venture Capital and Orbia Ventures.

Business overview

FortePhest is a biotechnology startup focused on developing solutions for herbicide-resistant weeds within the Agriculture & Food Technologies sector. The company's core product, H-Forte, is a herbicide that utilizes a newly discovered mechanism of action inspired by natural plant protectors. H-Forte targets the phenylalanine tRNA synthetase enzyme to disrupt protein synthesis in weeds, aiming to control resistant varieties. FortePhest primarily serves the agricultural market globally, operating in the sustainable farming, ag tech, and farm equipment & treatment categories.

Strategic signal

In February 2022, FortePhest received investment from BASF Venture Capital and Orbia Ventures. This strategic investment from two corporate venture arms signals strong industry validation for FortePhest's H-Forte technology and its potential to address the critical agricultural challenge of herbicide-resistant weeds. It suggests a forward trajectory towards commercialization and broader market adoption, leveraging the resources and expertise of major players in the chemical and infrastructure sectors.

Company Intelligence Q&A

What is FortePhest's primary focus?
FortePhest is a biotechnology startup developing technology to combat herbicide-resistant weeds, specifically through its H-Forte product.
When was FortePhest founded and by whom?
FortePhest was founded in August 2017 by co-founders Alex Kozak, Israel Shapiro, and Mark Safro.
Which investors participated in FortePhest's February 2022 funding round?
In February 2022, FortePhest received funding from BASF Venture Capital and Orbia Ventures.
What is the total capital raised by FortePhest?
FortePhest has raised a total of $1.4M across two funding rounds.
What is the mechanism of action for FortePhest's H-Forte herbicide?
H-Forte targets a key enzyme of protein synthesis, phenylalanine tRNA synthetase, to control resistant weeds by disrupting the structure of their proteins.